Democratic Underground Latest Greatest Lobby Journals Search Options Help Login
Google

New insight into treatment-resistant depression: a mutant gene

Printer-friendly format Printer-friendly format
Printer-friendly format Email this thread to a friend
Printer-friendly format Bookmark this thread
This topic is archived.
Home » Discuss » Archives » General Discussion (Through 2005) Donate to DU
 
Nothing Without Hope Donating Member (1000+ posts) Send PM | Profile | Ignore Sat Dec-18-04 11:01 PM
Original message
New insight into treatment-resistant depression: a mutant gene
This new finding could help avoid long series of unsuccessful treatments with inappropriate anti-depressant meds and contribute to understanding what causes a predisposition to treatment-resistant depression.

BTW, I have had treatment-resistant depression myself, and I have found acupuncture to be helpful.
---------------------

(snip)

Mutant Gene Linked To Treatment-Resistant Depression

A mutant gene that starves the brain of serotonin, a mood-regulating chemical messenger, has been discovered and found to be 10 times more prevalent in depressed patients than in control subjects, report researchers funded by the National Institutes of Health's National Institute of Mental Health (NIMH) and National Heart Lung and Blood Institute (NHLBI). Patients with the mutation failed to respond well to the most commonly prescribed class of antidepressant medications, which work via serotonin, suggesting that the mutation may underlie a treatment-resistant subtype of the illness.

The mutant gene codes for the brain enzyme, tryptophan hydroxylase-2, that makes serotonin, and results in 80 percent less of the neurotransmitter. It was carried by nine of 87 depressed patients, three of 219 healthy controls and none of 60 bipolar disorder patients. Drs. Marc Caron, Xiaodong Zhang and colleagues at Duke University announced their findings in the January 2005 Neuron, published online in mid-December.

"If confirmed, this discovery could lead to a genetic test for vulnerability to depression and a way to predict which patients might respond best to serotonin-selective antidepressants," noted NIMH Director Thomas Insel, M.D.

(snip)

Report from Science Daily News:
http://www.sciencedaily.com/releases/2004/12/041217102737.htm

Original NIH/NIMH news release and related links:
http://www.nimh.nih.gov/press/tryptophangene.cfm

Printer Friendly | Permalink |  | Top

Home » Discuss » Archives » General Discussion (Through 2005) Donate to DU

Powered by DCForum+ Version 1.1 Copyright 1997-2002 DCScripts.com
Software has been extensively modified by the DU administrators


Important Notices: By participating on this discussion board, visitors agree to abide by the rules outlined on our Rules page. Messages posted on the Democratic Underground Discussion Forums are the opinions of the individuals who post them, and do not necessarily represent the opinions of Democratic Underground, LLC.

Home  |  Discussion Forums  |  Journals |  Store  |  Donate

About DU  |  Contact Us  |  Privacy Policy

Got a message for Democratic Underground? Click here to send us a message.

© 2001 - 2011 Democratic Underground, LLC